MENU
Advertisement
Show Filters
Refine by Content Type
Refine by Year
Sort By:
Choose Sites to Search:
Coronary CTO Intervention
Practice development and economic effects.
By William L. Lombardi, MD, FACC, FSCAI, and Noah J. Jones, MD
FDA Approves TriReme's Glider PTCA Catheter
May 23, 2012—TriReme Medical, Inc. (Pleasanton, CA) announced approval by the US Food and Drug Administration (FDA) of the company's Glider percutaneous transluminal coronary angioplasty (PTCA) catheter, indicated for treating the stenotic portion of coronary arteries or bypass grafts to improve myocardial perfusion.
Coronary CTOs
By Ted E. Feldman, MD, Chief Medical Editor
Hemodynamic Support for PCI
An in-depth look at who, when, and how.
By Ravi S. Hira, MD, and William Lombardi, MD
